Table 2

Neuropsychological sequelae and management

All patients*HVILVIP value
Acute cohort
 No of patients592631
 Neuropsychological sequelae, no (%)14 (24)6 (23)7 (23)>0.99
Long-term cohort
 No of patients1225169
 Days to first follow-up, median (IQR)†201 (68–766)504 (179–1236)124 (41–233)<0.001
 Days to last follow-up, median (IQR)†980 (391–1409)1099 (511–1651)773 (315–1218)0.02
 Neuropsychological sequelae, no (%)
   <5 years postinjury99 (81)42 (82)56 (81)>0.99
   >5 years postinjury‡20 (27)13 (35)7 (20)0.19
 Psychological/
 psychiatric treatment, no (%)
78 (64)31 (61)47 (68)0.44
 Medication, no (%)78 (64)30 (59)47 (68)0.34
  • Analysis excludes patients with documented pre-existing psychiatric conditions.

  • *Includes patients whose voltage was not otherwise specified (acute cohort, n=2; long-term cohort, n=2).

  • †Calculated from the date of injury.

  • ‡Percentages are calculated based on the total number of patients that were available for follow-up at >5 years postinjury (all patients, n=74; HVI, n=37; LVI, n=35).

  • HVI, high-voltage injury; LVI, low-voltage injury.